# Zenas BioPharma, Inc.: Form SCHEDULE 13D, filed May 5, 2026

- Company: [Zenas BioPharma, Inc.](/companies/zbio.md) (CIK 1953926)
- Form: SCHEDULE 13D
- Filed: 2026-05-05
- Accepted by EDGAR: May 5, 2026, 16:15 ET
- Period: not reported
- Accession: 0001104659-26-055643
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1953926/000110465926055643/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1953926/000110465926055643/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1953926/000110465926055643/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-055643. Last ingested by Listed: Nov 6, 2026, 16:59 ET. No prices; not investment advice.